Johnson Controls International plc filings document an Irish public company with ordinary shares listed on the New York Stock Exchange and a capital structure that includes multiple series of senior notes and debentures, including sustainability-linked senior notes. Current reports on Form 8-K and amendments record material events and identify registered securities across equity and debt classes.
The company's proxy materials cover shareholder voting, board governance, executive compensation, sustainability governance and forward-looking risk disclosures. Form 25 records document exchange actions affecting listed debt securities, including removal from listing and registration of a note class.
Johnson Controls International plc (JCI) executive VP & President, Global Products reported a sale of company stock in a Form 4 filing. On 11/21/2025, the reporting person sold 32,031 ordinary shares of JCI at a weighted average price of $113.20 per share, with individual trade prices ranging from $112.61 to $113.55. After this transaction, the insider beneficially owns 66,780.5 ordinary shares, held directly. The filing notes that detailed trade-by-trade pricing information within the reported range is available upon request from the issuer, any security holder, or the SEC staff.
Johnson Controls International (JCI) shareholder plans sale under Rule 144. A holder has filed notice to sell 32,031 shares of JCI common stock through Morgan Stanley Smith Barney LLC on or about 11/21/2025 on the NYSE, with an aggregate market value of 3,625,902.79. JCI had 611,135,655 common shares outstanding at the time referenced in the notice, providing context for the size of the planned sale. The shares to be sold were acquired primarily through restricted stock vesting under a registered plan in multiple transactions between 12/08/2023 and 11/14/2025, in exchange for services rendered. Over the past three months, the same seller disposed of 10,500 JCI shares for gross proceeds of 1,281,380.10.
Johnson Controls International plc (JCI) reported an insider transaction by a company officer on Form 4. The reporting person, an officer serving as VP, President Global Field Ops, filed as a single reporting person. On 11/18/2025, this officer disposed of 5,384 ordinary shares of JCI at a price of $114.44 per share. Following this transaction, the officer beneficially owned 58,910.55 ordinary shares, held in direct ownership. The filing shows no derivative security transactions, as the derivative securities table contains no entries.
Johnson Controls International plc (JCI) reported a change in insider holdings by a company officer. On 11/14/2025, the VP & President, Global Products reported a disposition of 16,408 ordinary shares at a price of $118.72 per share. After this transaction, the reporting person directly beneficially owns 98,811.5 ordinary shares of JCI. The filing is made on Form 4 by a single reporting person, reflecting their role as an officer of the company.
Johnson Controls International plc (JCI) reported an insider transaction by a director. On 11/13/2025, the director made a bona fide gift (Code G) of 4,890 ordinary shares at $0. After this transaction, the director beneficially owned 9,987.63 shares, held directly.
Johnson Controls International plc filed its annual report for the year ended September 30, 2025, highlighting a streamlined portfolio and new regional structure. On July 31, 2025, the company completed the divestiture of its Residential and Light Commercial HVAC business to Bosch and realigned into three reportable segments: Americas, EMEA and APAC.
Execution metrics show solid demand: backlog totaled $16.6 billion at September 30, 2025, with Building Solutions orders of $20.7 billion (up 7% year over year) and remaining performance obligations of $22.7 billion. For fiscal 2025, products and systems represented 68% of sales from continuing operations, while services were 32%.
As context, the aggregate market value of common stock held by non‑affiliates was approximately $52.6 billion as of March 31, 2025. Ordinary shares outstanding were 611,135,655 as of October 31, 2025. The company remains a well‑known seasoned issuer and reports auditor attestation of internal control over financial reporting.
Johnson Controls International (JCI): insider transaction
The company’s VP & President, Global Products, reported selling 10,500 ordinary shares on 11/06/2025 at a weighted average price of $122.03. Following the sale, the officer directly holds 115,219.5 shares. The filing notes the sale occurred across multiple trades between $121.78 and $122.35.
Form 144 filing: A holder filed to sell up to 10,500 shares of common stock on the NYSE through Morgan Stanley Smith Barney LLC, with an aggregate market value of $1,281,380.10. The approximate sale date is 11/06/2025.
The shares were acquired via restricted stock vesting under a registered plan: 8,015 shares on 11/14/2023 and 2,485 shares on 12/12/2023, both for services rendered. Shares outstanding were 654,385,440 at the time stated in the notice.
JCI: A selling holder filed a Form 144 notice to sell up to 99,518 shares of common stock, reflecting an aggregate market value of $12,018,781.62. The planned sales are listed for 11/06/2025 on the NYSE through Morgan Stanley Smith Barney LLC Executive Financial Services.
The notice also reports recent sales activity: 1,422 shares on 09/02/2025 ($149,380.00), 1,422 on 10/01/2025 ($155,160.00), and 1,422 on 11/03/2025 ($162,800.00). Shares outstanding were 654,385,440; this is a baseline figure, not the amount being offered.
Johnson Controls International (JCI) filed a Form 3/A to amend an earlier report and include 2,540.53 phantom stock units held by an executive in a deferred compensation account. The amendment notes that 107 units accrued through dividend reinvestment since the original filing. Each phantom stock unit reflects the value of one ordinary share and settles 100% in cash upon the reporting person’s termination or retirement, subject to vesting. The executive’s title on 08/07/2023 was VP and President, EMEALA.